Myocardial infarction: lidocaine is ineffective given routinely.
|
|
|
Clinical bottom line (level 1a)
-
Patients with a myocardial infarction who are given lidocaine have no clear difference in mortality or ventricular fibrillation, than those given no lidocaine.
|
|
Sadowski et al:
American Journal of Cardiology
1999;
137 (5):
792-798
|
Expires March 2003
|
The study
Systematic review of randomised controlled trials
of
- Patients: myocardial infarction
- Intervention: lidocaine
compared with no lidocaine
- Outcome: mortality; ventricular fibrillation (VF)
Articles found in -
using -, -
(search terms: assessment of prior systematic reviews
)
and unclear
Selection criteria: randomised controlled trials
Appraisal criteria: not stated
Articles excluded if: not stated
21 trials with 12385 patients, combined by random effects model, including an original paper which is also reported in this article.
No significant heterogeneity (by eyeball).
The evidence
lidocaine vs placebo
| Outcome |
Time to outcome |
CER |
OR (95% CI) |
NNH (95% CI) |
| mortality
|
unknown |
/
(%) |
1.12 (0.91 to
1.36)
|
122
(NNT =
170
to infinity;
NNH = 44 to infinity)
|
| ventricular fibrillation
|
weeks |
/
(%) |
0.71 (0.47 to
1.09)
|
Comments
- Treatment with lidocaine appears ineffective at reducing death rates, despite its suppression of VF.
- The original data is from one of the few randomised trials of lidocaine use in acute ST-elevation MI in the thrombolytic era, and sits squarely with the results of the others.
- No stated search methodology weakens the study markedly.
Citation
-
Sadowski
ZP,
Alexander
JH,
Skrabucha
B, et al:
Multicenter randomized trial and a systematic overview of lidocaine in acute myocardial infarction.
American Journal of Cardiology
1999;
137 (5):
792-798
Contributor: Bob Phillips and Clare Wotton,
November 1999
Reviewer: Arnold Baas
Clinical Question.
| Patient |
myocardial infarction |
| Intervention or Exposure |
administration of lidocaine |
| Outcome |
mortality |
|
|